{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T09:14:11Z","timestamp":1771146851313,"version":"3.50.1"},"reference-count":122,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.canrad.2023.06.027","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:42:46Z","timestamp":1693269766000},"page":"588-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devices"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-957X","authenticated-orcid":false,"given":"C.","family":"Petit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Escande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sarrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Vaugier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7319-3670","authenticated-orcid":false,"given":"A.","family":"Tallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2023.06.027_bib0005","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.06.027_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/bjc.2012.575","article-title":"Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer","volume":"108","author":"Henson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2023.06.027_bib0015","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jtho.2018.05.028","article-title":"Dosimetric predictors of symptomatic cardiac events after conventional-dose chemoradiation therapy for inoperable NSCLC","volume":"13","author":"Yegya-Raman","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0020","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer","volume":"35","author":"Dess","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2014.11.037","article-title":"Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?","volume":"114","author":"Beukema","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijrobp.2022.08.013","article-title":"Cardiac substructures dosimetric predictors for cardiac toxicity after definitive radiotherapy in esophageal cancer","volume":"115","author":"Cai","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijrobp.2018.10.025","article-title":"Radiation dose-response for risk of myocardial infarction in breast cancer survivors","volume":"103","author":"Jacobse","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.canrad.2020.09.003","article-title":"Cardiac substructures exposure in left-sided breast cancer radiotherapy: is the mean heart dose a reliable predictor of cardiac toxicity?","volume":"25","author":"Naimi","year":"2021","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2023.06.027_bib0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13014-019-1234-z","article-title":"Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study)","volume":"14","author":"Jacob","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0050","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.prro.2019.09.015","article-title":"The meaningless meaning of mean heart dose in mediastinal lymphoma in the modern radiation therapy era","volume":"10","author":"Hoppe","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0055","first-page":"39","article-title":"Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines","volume":"19","author":"Beaton","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djk064","article-title":"Long-term risk of cardiovascular disease in 10-year survivors of breast cancer","volume":"99","author":"Hooning","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2023.06.027_bib0065","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1200\/JCO.2005.05.1037","article-title":"Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment","volume":"24","author":"Harris","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0075","doi-asserted-by":"crossref","first-page":"1007577","DOI":"10.3389\/fonc.2022.1007577","article-title":"Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer","volume":"12","author":"Banfill","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0080","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer","volume":"73","author":"Atkins","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtho.2020.11.002","article-title":"Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions","volume":"16","author":"Banfill","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0090","doi-asserted-by":"crossref","first-page":"e019476","DOI":"10.1161\/JAHA.120.019476","article-title":"Segmental cardiac radiation dose determines magnitude of regional cardiac dysfunction","volume":"10","author":"Trivedi","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.canrad.2023.06.027_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2023.01.085","article-title":"Demystifying the results of RTOG 0617: identification of dose sensitive cardiac subregions associated with overall survival","author":"McWilliam","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0100","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ijrobp.2022.11.033","article-title":"Left anterior descending coronary artery radiation dose association with all-cause mortality in NRG oncology trial RTOG 0617","volume":"115","author":"McKenzie","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2017.04.017","article-title":"Dose to heart substructures is associated with non-cancer death after SBRT in stage I\u2013II NSCLC patients","volume":"123","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0110","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jamaoncol.2022.4202","article-title":"Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer","volume":"8","author":"Kim","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2022.04.019","article-title":"Dose to the left anterior descending artery correlates with cardiac events following irradiation for breast cancer","author":"Zureick","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","article-title":"Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer","volume":"7","author":"Atkins","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.radonc.2017.01.008","article-title":"A cardiac contouring atlas for radiotherapy","volume":"122","author":"Duane","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2020.06.015","article-title":"Delineation of whole heart and substructures in thoracic radiation therapy: national guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups","volume":"150","author":"Milo","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.phro.2022.07.003","article-title":"Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans","volume":"23","author":"Walls","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2021.10.008","article-title":"Deep learning model for automatic contouring of cardiovascular substructures on radiotherapy planning CT images: dosimetric validation and reader study based clinical acceptability testing","volume":"165","author":"Garrett Fernandes","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10916-022-01810-6","article-title":"Automatic cardiac structure contouring for small datasets with cascaded deep learning models","volume":"46","author":"van den Oever","year":"2022","journal-title":"J Med Syst"},{"key":"10.1016\/j.canrad.2023.06.027_bib0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.prro.2022.02.004","article-title":"Development of simplified auto-segmentable functional cardiac atlas","volume":"12","author":"Loap","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0160","doi-asserted-by":"crossref","first-page":"085006","DOI":"10.1088\/1361-6560\/ab0ea6","article-title":"Feasibility of multi-atlas cardiac segmentation from thoracic planning CT in a probabilistic framework","volume":"64","author":"Finnegan","year":"2019","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2021.12.041","article-title":"Contouring cardiac substructures on average intensity projection 4D-CT for lung cancer radiotherapy: a proposal of a heart valve contouring atlas","volume":"167","author":"Socha","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0170","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.adro.2019.03.008","article-title":"Intrafractional displacement of cardiac substructures among patients with mediastinal lymphoma or lung cancer","volume":"4","author":"Guzhva","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0175","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00066-018-1299-x","article-title":"Spatial orientation of coronary arteries and its implication for breast and thoracic radiotherapy\u2014proposing \u201ccoronary strip\u201d as a new organ at risk","volume":"194","author":"Munshi","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0180","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.radonc.2020.09.044","article-title":"Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy","volume":"153","author":"Loap","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2016.12.029","article-title":"Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: an optimized organ at risk","volume":"122","author":"Lee","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0190","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2020.06.031","article-title":"Novel methodology to investigate the effect of radiation dose to heart substructures on overall survival","volume":"108","author":"McWilliam","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.1994.12.3.447","article-title":"Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy","volume":"12","author":"Cuzick","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaccao.2021.07.008","article-title":"Coronary artery disease in young women after radiation therapy for breast cancer: the WECARE study","volume":"3","author":"Carlson","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijrobp.2022.01.020","article-title":"Is radiation-induced cardiac toxicity reversible? Prospective evaluation of patients with breast cancer enrolled in a phase 3 randomized controlled trial","volume":"113","author":"Abraham","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10549-018-5053-y","article-title":"Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with trastuzumab-based chemotherapy","volume":"174","author":"Abouegylah","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.canrad.2023.06.027_bib0215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2016.08.024","article-title":"Risk of pacemaker or implantable cardioverter defibrillator after radiotherapy for early-stage breast cancer in Denmark, 1982\u20132005","volume":"122","author":"Rehammar","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/raon-2018-0035","article-title":"Pericardial disease after breast cancer radiotherapy","volume":"53","author":"Marinko","year":"2018","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0225","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.027_bib0230","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","article-title":"Risk of","volume":"135","author":"Saiki","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.canrad.2023.06.027_bib0235","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-015-0436-2","article-title":"Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy","volume":"10","author":"Skytt\u00e4","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0240","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0245","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2005.01.029","article-title":"The incidence and functional consequences of RT-associated cardiac perfusion defects","volume":"63","author":"Marks","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0250","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","article-title":"Radiation dose-volume effects in the heart","volume":"76","author":"Gagliardi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0255","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ijrobp.2010.01.004","article-title":"Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients","volume":"79","author":"Erven","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0260","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.3390\/cancers14235724","article-title":"Early coronary artery calcification progression over two years in breast cancer patients treated with radiation therapy: association with cardiac exposure (BACCARAT study)","volume":"14","author":"Honaryar","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2023.06.027_bib0270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13014-019-1242-z","article-title":"The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors","volume":"14","author":"Wennstig","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canrad.2014.01.001","article-title":"Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy","volume":"18","author":"Cao","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2023.06.027_bib0475","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2020.09.050","article-title":"Heart substructural dosimetric parameters and risk of cardiac events after definitive chemoradiotherapy for stage III non-small cell lung cancer","volume":"152","author":"Jang","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0470","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jtho.2016.09.134","article-title":"Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer","volume":"12","author":"Speirs","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0490","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2018.10.029","article-title":"Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer","volume":"133","author":"Xue","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0545","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.radonc.2011.08.040","article-title":"Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma","volume":"101","author":"Cella","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0530","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jrr\/rraa001","article-title":"Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram","volume":"61","author":"Takeuchi","year":"2020","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.canrad.2023.06.027_bib0525","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13014-020-01498-3","article-title":"Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer","volume":"15","author":"Pao","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0265","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1200\/JCO.2011.34.5900","article-title":"Distribution of coronary artery stenosis after radiation for breast cancer","volume":"30","author":"Nilsson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0275","doi-asserted-by":"crossref","first-page":"892882","DOI":"10.3389\/fonc.2022.892882","article-title":"Association between cardiac radiation exposure and the risk of arrhythmia in breast cancer patients treated with radiotherapy: a case-control study","volume":"12","author":"Errahmani","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0280","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.prro.2021.02.002","article-title":"A radiation therapy contouring atlas for cardiac conduction node delineation","volume":"11","author":"Loap","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0285","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00066-021-01777-2","article-title":"The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice","volume":"197","author":"Loap","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ctrv.2010.08.007","article-title":"Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessment","volume":"37","author":"Chargari","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2023.06.027_bib0295","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.027_bib0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.canrad.2023.06.027_bib0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12012-007-0013-5","article-title":"Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes","volume":"7","author":"Gianni","year":"2007","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0310","first-page":"161","article-title":"Cardiotoxicity and oncological treatments","volume":"111","author":"Schlitt","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.canrad.2023.06.027_bib0315","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ctrv.2009.04.012","article-title":"Combining systemic therapies with radiation in breast cancer","volume":"35","author":"Adamowicz","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2023.06.027_bib0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11886-021-01446-x","article-title":"Cardiovascular disease amongst women treated for breast cancer: traditional cytotoxic chemotherapy, targeted therapy, and radiation therapy","volume":"23","author":"Chen","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.canrad.2023.06.027_bib0325","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.027_bib0330","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10549-020-05930-w","article-title":"Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study","volume":"185","author":"Jacobse","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.canrad.2023.06.027_bib0335","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10549-014-3166-5","article-title":"Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study","volume":"148","author":"Jacob","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.canrad.2023.06.027_bib0345","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.027_bib0350","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.3390\/cancers13194790","article-title":"Pertuzumab and trastuzumab combination with concomitant locoregional radiotherapy for the treatment of breast cancers with HER2 receptor overexpression","volume":"13","author":"Aboudaram","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2023.06.027_bib0355","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.027_bib0360","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2014.58.7782","article-title":"Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer","volume":"33","author":"Krop","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0365","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/COC.0000000000000769","article-title":"Adjuvant trastuzumab emtansine (T-DM1) and concurrent radiotherapy for residual invasive HER2-positive breast cancer: single-center preliminary results","volume":"43","author":"Zolcs\u00e1k","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0370","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1185\/03007995.2013.807232","article-title":"Cardiotoxicity of novel HER2-targeted therapies","volume":"29","author":"Sendur","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.canrad.2023.06.027_bib0375","doi-asserted-by":"crossref","first-page":"e000082","DOI":"10.1161\/HCG.0000000000000082","article-title":"Impact of hormonal therapies for treatment of hormone-dependent cancers (breast and prostate) on the cardiovascular system: effects and modifications: a scientific statement from the American Heart Association","volume":"14","author":"Okwuosa","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.canrad.2023.06.027_bib0380","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer: a population-based cohort study","volume":"141","author":"Khosrow-Khavar","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.canrad.2023.06.027_bib0385","doi-asserted-by":"crossref","first-page":"k3845","DOI":"10.1136\/bmj.k3845","article-title":"Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review","volume":"363","author":"Matthews","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.canrad.2023.06.027_bib0390","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1136\/heartjnl-2017-312934","article-title":"Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors","volume":"104","author":"Grouthier","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.canrad.2023.06.027_bib0395","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijrobp.2010.03.044","article-title":"Role of systemic therapy in the development of lung sequelae after conformal radiotherapy in breast cancer patients","volume":"80","author":"Varga","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0400","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00066-005-1457-9","article-title":"Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects","volume":"181","author":"D\u00f6rr","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0405","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/annonc\/mdv602","article-title":"Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial","volume":"27","author":"Bourgier","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0410","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4329\/wjr.v4.i7.318","article-title":"Concurrent use of aromatase inhibitors and hypofractionated radiation therapy","volume":"4","author":"Chargari","year":"2012","journal-title":"World J Radiol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0415","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/14740338.2017.1351541","article-title":"Breast cancer treatment-induced cardiotoxicity","volume":"16","author":"Martel","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.canrad.2023.06.027_bib0420","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40259-019-00382-1","article-title":"Different cardiotoxicity of palbociclib and ribociclib in breast cancer: gene expression and pharmacological data analyses, biological basis, and therapeutic implications","volume":"33","author":"Santoni","year":"2019","journal-title":"BioDrugs"},{"key":"10.1016\/j.canrad.2023.06.027_bib0425","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","article-title":"Ribociclib as first-line therapy for HR-positive, advanced breast cancer","volume":"375","author":"Hortobagyi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.027_bib0430","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.027_bib0435","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jamaoncol.2022.5074","article-title":"Concurrent olaparib and radiotherapy in patients with triple-negative breast cancer: the phase 1 olaparib and radiation therapy for triple-negative breast cancer trial","volume":"8","author":"Loap","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0440","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.027_bib0445","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0450","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0455","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s40425-019-0718-6","article-title":"Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy","volume":"7","author":"Menon","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canrad.2023.06.027_bib0460","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0465","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","article-title":"Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for stage III non-small-cell lung cancer","volume":"125","author":"Wang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0480","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijrobp.2017.04.026","article-title":"The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer","volume":"99","author":"Vivekanandan","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2021.10.016","article-title":"Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: validation and new discoveries in an independent dataset","volume":"165","author":"Vivekanandan","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0495","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijrobp.2017.05.022","article-title":"Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer","volume":"99","author":"Ning","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0500","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(96)90447-5","article-title":"Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases","volume":"27","author":"Veinot","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0505","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.cllc.2017.08.002","article-title":"Survival impact of cardiac dose following lung stereotactic body radiotherapy","volume":"19","author":"Wong","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.canrad.2023.06.027_bib0510","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/cancers14061391","article-title":"Right atrial dose is associated with worse outcome in patients undergoing definitive stereotactic body radiation therapy for central lung tumors","volume":"14","author":"Farrugia","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2023.06.027_bib0515","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/cancers14051304","article-title":"The impact of radiation dose to heart substructures on major coronary events and patient survival after chemoradiation therapy for esophageal cancer","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2023.06.027_bib0520","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","article-title":"Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy","volume":"70","author":"Wei","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0535","doi-asserted-by":"crossref","first-page":"djv008","DOI":"10.1093\/jnci\/djv008","article-title":"Risk of valvular heart disease after treatment for Hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2023.06.027_bib0540","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.radonc.2015.07.043","article-title":"Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: a study based on patient specific artery segments dose calculation","volume":"117","author":"Moignier","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0550","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2023.06.027_bib0555","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/pace.12572","article-title":"Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study","volume":"38","author":"Zaremba","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0560","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.canrad.2021.11.003","article-title":"Radiotherapy for patient with cardiac implantable electronic device, consensus from French Radiation Oncology Society","volume":"26","author":"Escande","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2023.06.027_bib0565","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","article-title":"2022 ESC guidelines on cardio-oncology developed in collab oration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.canrad.2023.06.027_bib0570","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1002\/mp.13838","article-title":"Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: a report of the AAPM TG-203\u2020","volume":"46","author":"Miften","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0575","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.hrthm.2023.01.024","article-title":"Radiotherapy-induced malfunctions of cardiac implantable electronic devices: a meta-analysis","volume":"20","author":"Xu","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.canrad.2023.06.027_bib0580","doi-asserted-by":"crossref","first-page":"e13862","DOI":"10.1111\/eci.13862","article-title":"A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: prevalence and predictors of device malfunction in 3121 patients","volume":"53","author":"Malavasi","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.canrad.2023.06.027_bib0585","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/jce.15449","article-title":"Cardiac implantable electronic device dysfunctions in patients undergoing radiotherapy: a prospective cohort study","volume":"33","author":"Frey","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0590","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13014-020-01520-8","article-title":"Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks","volume":"15","author":"Gaasch","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.027_bib0595","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","article-title":"Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?","volume":"92","author":"Aznar","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0600","doi-asserted-by":"crossref","DOI":"10.1002\/mp.16398","article-title":"Acute coronary event (ACE) prediction following breast radiotherapy by features extracted from 3D CT, dose, and cardiac structures","author":"Choi","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.canrad.2023.06.027_bib0605","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.canrad.2023.06.027_bib0610","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaccao.2021.06.003","article-title":"Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the International Cardio-Oncology Society","volume":"3","author":"Mitchell","year":"2021","journal-title":"JACC CardioOncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823001385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823001385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:37:30Z","timestamp":1761136650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321823001385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":122,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1278321823001385"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2023.06.027","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devices","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2023.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}